Delivery Order SPE2DR25D3501-SPE2DR26FM5TA
Award Date 3/4/26
Potential Completion Date 3/5/26
Potential Value $3.9K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 6, 2026, with a ceiling value of $2,030.61 for Abilify Maintena ER 400 MG syringes, under a firm fixed-price structure with an ultimate completion date of March 9, 2026.</p> <p>Place of performance is Conshohocken, PA. The order was issued under no set-aside.</p>
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, with a ceiling value of $21,954.97, for supply of Abilify Maintena ER 400 mg syringes. Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 6, 2026. Pricing is firm fixed price. The order was issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 and running through December 2026, which serves as...
- The Defense Logistics Agency awarded a $4,531.06 delivery order to AmerisourceBergen Drug Corp for Abilify Maintena ER 400 mg syringes, with an ultimate completion date of September 12, 2025. This is a firm fixed price contract with no set-aside designation, awarded on a competitive basis. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 300 mg syringes under a firm fixed-price contract valued at $3,147.13. The award, made on September 25, 2025, represents a non-set-aside competitive procurement with an ultimate completion date of September 26, 2025. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical delivery. This delivery...
- The Defense Logistics Agency awarded a $3,785.30 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This non-set-aside contract was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This competitively awarded, firm fixed-price delivery order was issued on October 16, 2025, with an ultimate completion date of October 17, 2025. The award carries no set-aside designation, indicating open competition among qualified vendors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this...
- <p>The Defense Logistics Agency issued a $4,986.44 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for Abilify 2 mg tablets (30-count package), with an ultimate completion date of March 9, 2026.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract, a $999,999,999 global pharmaceutical supply vehicle running through December 2026. Place of performance is Conshohocken, Pennsylvania. Pricing is firm fixed price with no set-aside applied.</p>
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,667.50 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 300 mg syringes, with performance at the company's corporate office location in Conshohocken, Pennsylvania. This competitive delivery order, issued on December 11, 2025, with an ultimate completion date of December 12, 2025, carries firm fixed pricing and no set-aside designation. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Abilify Maintena ER 400 mg vials/syringes with a ceiling value of $1,784.28. This firm fixed-price delivery order, with an ultimate completion date of November 14, 2025, represents a continuation of pharmaceutical support under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,438.27 for Abilify Maintena ER 400 mg syringes, with an ultimate completion date of August 28, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate headquarters operates. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM5TADelivery Order
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 4, 2026, for Abilify Maintena ER 400 mg syringes with a ceiling value of $3,910.31, under its pharmaceutical supply contract with the DLA Troop Support Medical. Place of performance is Conshohocken, PA. Ultimate completion date is March 5, 2026. The order carries firm fixed pricing and was issued without a set-aside.
Generated 6/2/26, 9:54 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 3/3/26 |